Optimize your Market Access strategies and fund your growth
HealthTech180 is a one-stop Consulting and Financial Advisory boutique specialized in Healthcare (Pharma, Biotech, Medical Device, Diagnostics, Digital Health and Cosmetics).
We are a group of experienced executives, consultants, doctors, investors and financial advisors who bring a diverse and deep experience to every healthcare engagement.
We are Market Access specialists that will take your business to the next level by finding the right investors, distribution partners or by negotiating the best licensing deals. We pride ourselves on providing the best service to all our clients – helping them every step of the way.
The members of our Team always take a hands-on approach with integrity, trust and commitment.
Services : your needs are our priorities
With a strong track record in Funding and M&A, we are your one-stop shop for your growth needs. We offer Funding, Market Access, Distribution and Licensing services. We will define the best market access strategy while ensuring it is implemented with the most trustworthy partners.
72% of PE and VC investors find it difficult to Access high-quality cross border targets in the healthcare sector.
For 94% of PE and VC investors, aggressive value creation is key in the healthcare sector.
Our services are 100% covered by our experienced and renowned experts. Check our Team´s profiles!
HealthTech180 is 180% committed to the success of our clients!
Daily updates from the HealthTech sector, and about HT180 and our advisors: Buy-Outs, Licensing, Funding Rounds, Regulatory etc. Important news not to be missed! Follow us on Linkedin and Twitter.
LUNAC Therapeutics has spun out of the University of Leeds with €3.09M of funding from the university and the VC firm Epidarex Capital for the
Dragonfly Therapeutics, a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease, announced that the first patient was dosed in
FUJIFILM Diosynth Biotechnologies Announces $55 Million USD Investment To Expand Gene Therapy Development Capabilities
FUJIFILM Diosynth Biotechnologies will be expanding its gene therapy process and analytical development capabilities with the addition of new dedicated laboratorios. FUJIFILM Diosynth Biotechnologies (FDB),